Sandbox: wdx causes: Difference between revisions

Jump to navigation Jump to search
Line 94: Line 94:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" + |Transfusion<ref name="pmid14712429">{{cite journal |vauthors=Gupta M, Wadhwa NK, Bukovsky R |title=Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate |journal=Am. J. Kidney Dis. |volume=43 |issue=1 |pages=67–73 |date=January 2004 |pmid=14712429 |doi= |url=}}</ref>
! colspan="2" align="center" style="background:#DCDCDC;" + |Transfusion<ref name="pmid14712429">{{cite journal |vauthors=Gupta M, Wadhwa NK, Bukovsky R |title=Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate |journal=Am. J. Kidney Dis. |volume=43 |issue=1 |pages=67–73 |date=January 2004 |pmid=14712429 |doi= |url=}}</ref>
Line 120: Line 120:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |History of administration of large quantities of [[blood]] products that contain [[sodium citrate]]
| align="center" style="background:#F5F5F5;" + |History of administration of large quantities of [[blood]] products that contain [[sodium citrate]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
* Associated with [[Renal insufficiency|renal impairment]]
* Associated with [[Renal insufficiency|renal impairment]]
|-
|-
Line 152: Line 152:
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Contraction alkalosis  
| align="left" style="background:#F5F5F5;" + |
* Contraction alkalosis  
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" + |Penicillin
! colspan="2" align="center" style="background:#DCDCDC;" + |Penicillin

Revision as of 15:24, 17 May 2018

Metabolic Alkalosis

Differential diagnosis of metabolic alkalosis is as follow:[1]

Category Disease Mechanism Clinical Paraclinical Gold standard diagnosis Other findings
Symptoms Signs Lab data
ABG Chemistry Enzyme Renal function
Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl
Exogenous HCO3 loads Acute alkali administration[2] + + + Nl Clinical
Milk−alkali syndrome[3] + + + + Nl
Transfusion[4] - + - - ± + - + - History of administration of large quantities of blood products that contain sodium citrate
Drugs/Medication Chloruretic diuretics
  • Bumetanide
  • Chlorothiazide
  • Metolazone
+ + +
  • Contraction alkalosis  
Penicillin +
Licorice + +
Laxative abuse +
Antacids 
  • Aluminum hydroxide
  • Sodium polystyrene sulfonate  
+
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Gastrointestinal origin Vomiting + + +
Nasogastric tube suction + + +
Zollinger−Ellison syndrome
Bulimia + +
Congenital chloridorrhea + +
Pyloric stenosis +
Villous adenoma + +
Gastrocystoplasty +
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Renal origin HTN
Posthypercapnic state + +
Hypomagnesemia Nl
Hypokalemia + Nl
Bartter's syndrome + + Nl
Gitelman’s syndrome + +
Renal artery stenosis Nl
Liddle syndrome +
Renal tumors
Endocrine Cushing's syndrome Nl
Hyperaldosteronism Primary Nl
Secondary
Adrenal enzyme defects 11β−Hydroxylase deficiency
17α−Hydroxylase deficiency
Hypercalcemia/hypoparathyroidism +
Systemic Cystic fibrosis  +
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
  1. Galla JH (February 2000). "Metabolic alkalosis". J. Am. Soc. Nephrol. 11 (2): 369–75. PMID 10665945.
  2. Máttar, João A.; Weil, Max Harry; Shubin, Herbert; Stein, Leon (1974). "Cardiac arrest in the critically III". The American Journal of Medicine. 56 (2): 162–168. doi:10.1016/0002-9343(74)90593-2. ISSN 0002-9343.
  3. Abreo, Kenneth (1993). "The Milk-Alkali Syndrome". Archives of Internal Medicine. 153 (8): 1005. doi:10.1001/archinte.1993.00410080065011. ISSN 0003-9926.
  4. Gupta M, Wadhwa NK, Bukovsky R (January 2004). "Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate". Am. J. Kidney Dis. 43 (1): 67–73. PMID 14712429.